Financials

Discussions Technicals Seasonals

4888 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Stella Pharma Corp. engages in the development, manufacture, and sale of pharmaceuticals. It provides boron-based drugs used for Boron Neutron Capture Therapy (BNCT), a form of radiotherapy that targets cancer cells using biochemical methods. The company was founded on June 1, 2007 and is headquartered in Osaka, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4888 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company